Inovio Pharmaceuticals Inc vs Vodafone Group Plc American Depositary Shares — how do they compare? Inovio Pharmaceuticals Inc trades at $1.11 (market cap $119.42M), while Vodafone Group Plc American Depositary Shares trades at $16.5 (market cap $39.26B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 328.8× Inovio Pharmaceuticals Inc's market cap, and Vodafone Group Plc American Depositary Shares pays a 3.2% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and Vodafone Group Plc American Depositary Shares for 0 Days on average.
| INO | VOD | |
|---|---|---|
Market Cap | $119.42M | $39.26B |
Volume | 2,789,649 | 4,020,412 |
Sector | Health | Media |
52-Week High | $2.65 | $17.68 |
52-Week Low | $0.66 | $11.17 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | $90.75M | $84.62B |
Dividend Yield | — | 3.2% |
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.09, down 3.54% on the day, with a bearish technical signal driven by moving averages. The company reported a net loss of $84.95 million in 2025 on minimal revenue of $65,340, with negative profitability metrics, but has beaten EPS estimates in recent quarters. Key near-term catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107.
The investment case hinges on regulatory approval of INO-3107, with a consensus price target of $2.75 implying significant upside. However, extreme financial losses, high cash burn, and dependence on dilutive financing pose substantial risks. Analyst sentiment is cautiously optimistic but reflects high uncertainty.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.
Read more on VOD →